Valent BioSciences Unveils New Biorational Research Center

FOR IMMEDIATE RELEASE

Grand Opening event attracts attendees from around the world to tour high tech facility

Libertyville, IL, July 25, 2018 — Valent BioSciences (VBC) officially opened the doors of its new global research facility, the Biorational Research Center (BRC), at a July 24thgala at Libertyville’s stylish Innovation Park. More than 250 guests, ranging from the Deputy Governor of the State of Illinois, to strategic partners, customers, allied industry representatives, and leading members of the scientific community gathered to join Grand Opening festivities and tour the 85,000 square-foot facility adjacent to the company’s long-time headquarters.

The opening of the BRC completes a two-year build-out and transition from VBC’s legacy research facility in nearby Long Grove, IL. The facility boasts approximately 65,000 square-feet of open-concept lab and office space combined with a state-of-the-art, 20,000 square-foot greenhouse. In addition to its technological upgrades, the move is intended to streamline cross-functional collaboration among VBC’s industry-leading team of innovative plant, soil, and formulation scientists, microbiologists, entomologists, and chemists – a team that brings best-in-class solutions to agriculture, public health, and forest health professionals around the world.

“This breathtaking new facility is a testimony to the notable success of our R&D group,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “All patents and awards aside, that success ultimately comes down to an ability to develop and commercialize sustainable products that deliver clear value to our stakeholders – whether they be growers, food companies, foresters, or governments that fight against insect-borne disease.”

The BRC is the latest addition to the Sumitomo Chemical Company (SCC) Biorational Research Network (BRN), a strategic enterprise that includes both internal resources and external (3rdparty) expertise. As the parent company to VBC, SCC deploys a global team of scientists operating in lab and field research facilities at key locations around the globe. Central to the BRN mission are investigations that brings together biorational and conventional technologies that work in harmony with nature.

The opening of the BRC is another in a string of investments VBC has made into its burgeoning biorational business over recent years. In addition to the acquisition of Pace International (2012) and Mycorrhizal Applications (2015), VBC also opened its Iowa-based $150 million biorational manufacturing plant in 2014, the first ever purpose-built biorational facility in the world.

# # #

About Valent BioSciences

Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorationalproducts with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

Media Contact:

Rick Melnick
Valent BioSciences
847-968-4750

Email: rick.melnick@valentbiosciences.com

Download News Release

Danforth Plant Science Center and Valent BioSciences will Collaborate in Unique Root Science Initiative

FOR IMMEDIATE RELEASE

Master Agreement will focus on improving agriculture with non-destructive imaging technology for root growth dynamics

LIBERTYVILLE, IL, July 11, 2016 – Valent BioSciences Corporation (VBC) and the Donald Danforth Plant Science Center today announced the finalization of a multi-year, Master Cooperation Agreement in the area of root science and the rhizosphere. Located in St. Louis, MO, the Danforth Center is among the world’s preeminent institutes for research and innovation surrounding plant science and associated technologies. VBC is a wholly-owned subsidiary of Sumitomo Chemical Company and a global leader in the research, development, and commercialization of biorational technology for agriculture, public health and forestry.

“We are pleased to be entering into this agreement with a partner that has such demonstrated success in plant science innovation”, said James Carrington, Ph.D., president of the Danforth Plant Science Center. “We view our imaging work as a potentially game-changing technology that warrants a collaborator with a global view and a full complement of proven, effective technologies to help us improve the human condition through plant science. VBC was our first choice.”

Until now, the only way for plant scientists to observe in-field root development has been to extract them from the soil. For the first time, today’s advanced imaging technology allows real-time data gathering in a way that is non-destructive and non-disruptive to future plant development.

The agreement is designed to maximize outcome potential by intersecting core competencies from within the two organizations. The Danforth Center focuses on discoveries and technologies for improving agricultural productivity with minimal environmental impact including new research on non-destructive imaging technology for root growth dynamics. Over the last two years, VBC has made sizeable commitments to rhizosphere technologies including the acquisition of Mycorrhizal Applications, LLC (MA) and several licensing and research agreements designed to accelerate its root zone portfolio.

“It was an honor to be approached by the Danforth Center as a collaborator for this significant body of work,” said Dr. Warren Shafer, Vice President of R&D and Regulatory Affairs for Valent BioSciences. “There is an obvious overlap in mission and purpose between the two organizations, and our knowledge and respective technologies are clearly complementary. Together, they hold tremendous potential for our stakeholders.”

Danforth Center Principal Investigator Chris Topp, Ph.D., was recently awarded a grant from the National Science Foundation to support his work combining root phenotyping technologies with computational analysis, quantitative genetics and molecular biology to understand root growth and physiology. The NSF and VBC agreements will jointly fund a large-scale X-ray imaging system for non-invasive root measurements, the first of its kind dedicated for plant science in the U.S. academic research sector.

Through MA and SyMyco Inc., a joint venture in which MA participates, VBC brings the world’s foremost experts in the study and propagation of mycorrhizae – beneficial fungi that colonize plant roots to enhance nutrient uptake and water efficiency. VBC also has research agreements in place with BioMar, LidoChem, and Rhizobacter, all established leaders in emerging biorational technology for the rhizosphere and beyond.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About the Danforth Plant Science Center
Founded in 1998, the Donald Danforth Plant Science Center is a not-for-profit research institute with a mission to improve the human condition through plant science. Research, education and outreach aim to have impact at the nexus of food security and the environment, and position the St. Louis region as a world center for plant science. The Center’s work is funded through competitive grants from many sources, including the National Institutes of Health, U.S. Department of Energy, National Science Foundation, and the Bill & Melinda Gates Foundation.

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s total consolidated sales for fiscal year 2015 were JPY 2.1 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About Mycorrhizal Applications, LLC
Headquartered in Grants Pass, OR, Mycorrhizal Applications LLC (MA) grows mycorrhizal seeds, or “spores,” used to produce mycorrhizal plants that improve soil health and increase nutrient and water uptake and efficiency. Working hand-in hand with the forestry, agricultural, ornamental, turf, and nursery industries, MA prides itself in its commitment to sustainability, customer service, and quality products based on and sound science. For additional information, visit the company’s website at http://mycorrhizae.com

About SyMyco Inc.
SyMyco was founded in 2010 and is headquartered at the Bio-Research and Development Growth Park at the Danforth Plant Science Center in St. Louis; SyMyco research and production are focused on mycorrhizal fungi which expand a plant’s roots by adding thousands of absorbing fungal hyphae. These fungi play a critical role in the health and productivity of 90 percent of plant species in natural areas and form with most major crop species and also reduce the need for water and chemical fertilizers. For more information, visit the company’s website at http://www.symyco.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Melanie Bernds
Donald Danforth
Plant Science Center
314-587-1647
Email:mbernds@danforthcenter.org

Download News Release

Valent BioSciences Corporation and Rizobacter Enter R&D Cooperation Agreement for Biorationals

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL and PERGAMINO, ARGENTINA, March, 31, 2016 – Valent BioSciences Corporation (VBC) announced today it has signed a long-term cooperation agreement with Rizobacter for R&D collaboration in the BioRational Rhizosphere space – initially for the NAFTA region. The alliance will further accelerate VBC’s development and commercialization of new microbial products for the root zone as part of its expanding seed and soil strategy. Driving the strategic partnership is the increasing need to accelerate the research and development of sustainable agriculture solutions to feed a growing world population.

VBC is a wholly-owned subsidiary of Sumitomo Chemical and a global leader in developing and marketing biorational technologies for agriculture, forestry, and public health. The company’s recent focus in the soil space has been the development of formulation and application technology for proprietary strains of mycorrhizal fungi. Rizobacter is a global leader in microbiological solutions for seed treatment with recent innovations pertaining to microbial nitrogen management as well as biocontrol of several important plant diseases. Both companies boast renowned expertise in industrial fermentation and formulation science for microbial products.

“This collaboration with Rizobacter reinforces our ongoing commitment to bring cutting- edge microbial technologies into our industry-leading biorational product line,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “It is an alliance that brings together some of the most gifted and experienced minds in our industry along with two robust pipelines with tremendous potential for developing complementary technologies that will bring value to our customers.”

It is envisioned that R&D as well as industrial scale fermentation will be conducted both in Argentina and the US. Beyond working collaboratively to develop the next generation of rhizosphere products, the strategic partnership expects to develop a variety of technologies and know-how that will advance the overall understanding of interactions in the rhizosphere. Valent U.S.A. will serve as the commercialization partner in this collaboration for NAFTA. A release outlining details of that partnership is expected from Valent USA in the near future.

“We are proud to have the opportunity to work with VBC, and partner on this strategic project. We are committed to the shared mission of developing new technology, and to invest in research in order to provide better solutions to global farmers. Entering into this strategic partnership represents a significant step towards our goal of expanding our product portfolios worldwide” said Ricardo Yapur, CEO of Rizobacter.

The collaboration comes one year after VBC’s acquisition of Mycorrhizal Applications. VBC and other affiliates of parent Sumitomo Chemical are closely aligning development of biorationals and conventionals to further strengthen their global plant protection and enhancement businesses.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Sumitomo Chemical and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About Rizobacter
Headquartered in Pergamino, Argentina, Rizobacter is a leading company in the development, manufacturing and commercialization of microbiological products applied to agriculture. Rizobacter is delivering state of the art technologies in 27 Countries. This partnership will contribute new products to the company’s ambitious global expansion plan. Rizobacter is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.rizobacter.com

About Valent U.S.A. Corporation
Valent U.S.A. Corporation, headquartered in Walnut Creek, Calif., is a subsidiary of Tokyo-based Sumitomo Chemical. Valent U.S.A. develops and markets products in the United States and Canada that protect agricultural crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and also biorational products developed by its affiliate, Valent BioSciences Corporation. For additional information, visit the company’s website at www.valent.com

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s consolidated net sales for fiscal year 2014 were JPY 2.38 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

Media Contact:
Valent BioSciences Corporation
Rick Melnick
847-968-4750
Email: rick.melnick@valentbiosciences.com

Rizobacter
María Bulla
+542477409400 Ext 117
Email: mbulla@rizobacter.com

Download News Release

Valent BioSciences Corporation Reaches Global Licensing Agreement with LidoChem, Inc. for New Biocontrol Technology to Protect Against Nematodes

FOR IMMEDIATE RELEASE

Valent BioSciences Corporation Reaches Global Licensing Agreement with LidoChem, Inc. for New Biocontrol Technology to Protect Against Nematodes

LIBERTYVILLE, IL, March, 28, 2016 – Valent BioSciences Corporation (VBC) announced today it has reached a global licensing agreement with LidoChem, Inc. for a novel, patented biocontrol technology for use in corn, soybean, and other crops. Based on a unique strain of the beneficial soil microorganism Bacillus amyloliquefaciens, it will be developed by VBC in collaboration with Valent U.S.A. Corporation. VBC and Valent U.S.A. are wholly-owned subsidiaries of Sumitomo Chemical, a global leader of conventional plant protection and biorational technologies for agriculture.

The product will be marketed and sold initially as a biological nematode seed treatment for the U.S. market by Valent U.S.A. The U.S. EPA registration is expected this year. VBC plans to focus future research and development on new formulations and expansions of the technology into other applications, crops, and regions.

“This agreement brings another important and innovative biorational technology to our growing platform for soil-based innovation,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “The unique mode of action of the product brings growers a potent and valuable tool in their battle against soilborne pests.”

LidoChem, Inc. Chief Executive Officer Don Pucillo said the agreement with VBC delivers on a key performance goal for the product.

“Strong technologies require strong development and distribution partners,” said Pucillo. “LidoChem is pleased to have reached an agreement with a trusted company known around the world for delivering consistent, measureable value to growers through innovative biorational technologies.”

Valent U.S.A. Business Unit Director Trey Soud said the LidoChem deal further expands the Valent seed protection solutions available to growers.

“This exciting new technology will be a strong complement to our well-established seed protection portfolio,” said Soud. “The addition of this biological strengthens our ability to provide growers with control against nematodes and provide them with complete seed treatment solutions. Longer term, we are looking aggressively at various application methods that can deliver this technology and others more conveniently for growers.”

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About Valent U.S.A. Corporation
Valent U.S.A. Corporation, headquartered in Walnut Creek, Calif., is a subsidiary of Tokyo-based Sumitomo Chemical. Valent U.S.A. develops and markets products in the United States and Canada that protect agricultural crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and also biorational products developed by its affiliate, Valent BioSciences Corporation. For additional information, visit the company’s website at www.valent.com

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s total consolidated sales for fiscal year 2014 were JPY 2.38 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About LidoChem, Inc.
LidoChem, Inc., a family-owned business, was established in 1981 and is based in Hazlet, New Jersey. LidoChem, Inc., has two divisions: the Industrial Division, which distributes chemical raw materials; and the Performance Nutrition Division, established in 1999 to develop, market and distribute environmentally friendly and effective crop, turf & ornamental fertility and disease control products and programs. Today Performance Nutrition patented product lines include: NutriSmart® biological eco-fertilizer; KaPre® soil amendments and fertilizer additives; ArgosyTM patented adjuvants; Prudent® patented phosphite fertilizers; Vibrant® patented foliar fertilizers; Pennamin® water-soluble amino acid chelated micronutrients; and others. Performance Nutrition’s proprietary Nutrol® is a fungicide, tank buffer & water-soluble fertilizer. Find LidoChem on Facebook, Twitter, and at www.performancefertilizers.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Download News Release

Valent BioSciences Corporation Reaches Distribution Deal for Actinovate® Brands with The BioAg Alliance

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL, January, 19, 2016 – Valent BioSciences Corporation (VBC) announced it has reached an agreement with The BioAg Alliance to distribute certain Actinovate® Biological Fungicide products. Through the agreement, Actinovate® AG brand sales for the United States will be handled through Valent U.S.A. Corporation and for Canada by Valent Canada, Inc.

Actinovate® AG is a broad spectrum biofungicide product for management of common foliar and soilborne diseases found on outdoor crops and in greenhouses, nurseries, and turf. The move aims to further strengthen the Valent Group’s biorational offering while leveraging its substantial penetration into the biocontrol and disease management market.

“We are pleased to add a quality product such as Actinovate® AG to our industry- leading biorational product line,” said Ted Melnik, executive vice president and chief operating officer of VBC. “Actinovate® AG is a proven product that offers growers a flexible tool for fighting disease and managing resistance while providing value across a wide range of plants and crops.”

“The BioAg Alliance is pleased to work with Valent BioSciences to deliver this new solution to their customers,” said Brad Griffith, Vice President of Global Microbials for Monsanto. “We are focused on being the preferred development and commercial partner in ag microbials worldwide, bringing value to our partners and this agreement is a great example of this work. The BioAg Alliance brings an unmatched ability to take ag microbial products from idea to market – including access to premier formulation, testing, production, and regulatory capabilities.”

The deal comes on the heels of VBC’s recent acquisition of Mycorrhizal Applications and its 2012 acquisition of Pace International. Valent U.S.A. and other affiliates of parent Sumitomo Chemical Company, Limited are closely aligning development of conventionals and biorationals to further strengthen their global crop protection and enhancement businesses.

Valent U.S.A. executive vice president and chief operating officer Matt Plitt said “The Actinovate® AG deal builds on the company’s goal to provide growers with an integrated portfolio of valuable plant protection tools.”

A broad spectrum biofungicide product, Actinovate® AG Biological Fungicide, offers growers with an excellent option for multiple growing practices, including organic, sustainable or conventional production systems. Actinovate® AG is OMRI-approved with the lowest possible re-entry interval and zero day preharvest interval, giving growers flexibility to fit their production plan.

“Growers are looking for smart technologies from planting all the way through to postharvest uses,” Plitt said. “Actinovate® AG products are a good fit for our balanced portfolio that leverages the benefits of biorational and conventional products in an integrated program to bring out the best in every plant.”

The distribution agreement includes outdoor crops, greenhouse, nursery and turf uses of the Actinovate® AG brands – Actinovate® AG, Actinovate® L&G, Actinovate® SP and Actino-Iron®. Mycorrhizal Applications will also distribute Actino Iron as an ingredient into the specialty potting soil market. Seed treatment uses will be retained by the BioAg Alliance.

For more information about Actinovate® visit www.valent.com or www.valent.ca.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About Valent U.S.A. Corporation
Valent U.S.A. Corporation, headquartered in Walnut Creek, Calif., develops and markets products in the United States and Canada that protect agricultural crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and also biorational products developed by its affiliate, Valent BioSciences Corporation. For additional information, visit the company’s website at www.valent.com

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of petrochemicals, energy and functional materials, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s consolidated net sales for fiscal year 2014 were JPY 2.38 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About The BioAg Alliance
First announced in December 2013, The BioAg Alliance is unique in the industry, bringing together Novozymes’ BioAg operations and capabilities within microbial discovery, development and production with Monsanto’s microbial discovery, advanced biology, field testing and commercial capabilities. The result is a comprehensive discovery, development and commercial collaboration to help farmers globally meet the challenge of producing more with less in a sustainable way – for the benefit of agriculture, consumers, the environment and society at large.

Media Contacts:
Valent BioSciences Corporation
Rick Melnick
847-968-4750
Email: rick.melnick@valentbiosciences.com

The BioAg Alliance
Johan Melchior,
Novozymes
+45-3077-0690
Email: jmel@novozymes.com

Lee Quarles, Monsanto
314-694-6397
Email: lee.quarles@monsanto.com

Actino-Iron is a registered trademark of Novozymes A/S. Actinovate is a trademark of Monsanto Technology, LLC.

Download News Release

Valent BioSciences Corporation Acquires Mycorrhizal Applications, Inc.

FOR IMMEDIATE RELEASE

Industry leader adds innovative technology platform to further expand its rapidly growing biorational business

LIBERTYVILLE, IL, March 4, 2015 – Valent BioSciences Corporation (VBC), the leader in biorational product development for agriculture, public health, and forestry worldwide, announced today it has acquired Mycorrhizal Applications, Inc. (MA), the world’s largest producer of mycorrhizal fungal inoculum. Mycorrhizal inoculation increases plant productivity by forming a symbiotic relationship with plant roots. Mycorrhizal hyphae attach to roots and radiate out into soil, enhancing access to nutrients and water made available to plants.

The acquisition adds another strategic platform to VBC’s rapidly expanding global biorational business, providing additional tools for the Biorational Window platform being developed with its parent, Sumitomo Chemical Co., Ltd. (SCC).

“The acquisition of Mycorrhizal Applications will allow us to accelerate the development of our rhizosphere strategy and immediately reinforce our strength in the biorational business,” said Ted Melnik, Executive Vice President and Chief Operating Officer of VBC. “The move affords us the unique opportunity to leverage our internal resources and develop an entire suite of innovative rhizosphere products and technologies that expands our portfolio to meet the needs of growers around the world.”

Founded in 1995 and headquartered in Oregon, MA’s earliest products were developed for forestry and nursery applications. Nearly 90% of the world’s plants form an association with mycorrhizal fungi, which colonize plant roots and provide the host with enhanced capacity for water and mineral uptake. In exchange, the fungi benefit from access to plant carbohydrates, which they use for food. Today, MA’s business has grown to include products for commercial agriculture, manufactured soils, turf, landscape and restoration.

The company’s leading brand, MycoApply®, is sold in powder, granular, and liquid form. Melnik said a dedicated R&D budget, earmarked for rhizosphere product development, has been established to coincide with the acquisition. VBC anticipates a host of new uses, with widespread agricultural applications, being developed in the next few years. Globally, MycoApply® will be sold through the SCC affiliate network. Valent U.S.A.

Corporation will handle commercialization of the Mycorrhizal Applications pipeline and portfolio in Agricultural crops in the NAFTA region, including marketing, product development and sales through associated distribution networks. With this innovative platform technology, Valent U.S.A. will create crop protection and enhancement solutions that complement its existing portfolio to deliver more value to its customers.

“We’re very excited to become part of the VBC and SCC family,” said Dr. Mike Amaranthus, the renowned rhizosphere scientist who co-founded the business with wife, Eileen. “While we will provide our customers with the same quality products and expert support they’ve come to expect from us, VBC’s investment will further accelerate our innovation and increase our capacity to meet the growing demand for our products and food and fiber, globally. Our goal is to make mycorrhizal inoculation an essential tool to increase plant productivity while improving the quality of our lives and the environment. VBC provides the fundamental capacity for achieving that goal.”

Johan Pienaar, Global Business Manager for VBC’s plant growth regulator business, will become the new Chief Operating Officer of MA, reporting directly to Ted Melnik. Pienaar will operate out of the Grants Pass office.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com

About Mycorrhizal Applications, Inc.
Headquartered in Grants Pass, OR, Mycorrhizal Applications Inc. (MA) grows mycorrhizal seeds, or “spores,” used to produce mycorrhizal plants that improve soil health and increase nutrient and water uptake and efficiency. Working hand-in hand with the forestry, agricultural, ornamental, turf, and nursery industries, MA prides itself in its commitment to sustainability, customer service, and quality products based on and sound science. For additional information, visit the company’s website at http://mycorrhizae.com/

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of basic chemicals, petrochemicals, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s total consolidated sales for fiscal year 2013 were JPY 2.24 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About Valent U.S.A. Corporation
Valent U.S.A. Corporation, headquartered in Walnut Creek, Calif., develops and markets products in the United States and Canada that protect agricultural crops, enhance crop yields, improve food quality, beautify the environment and safeguard public health. Valent products include a well-known line of quality herbicide, insecticide, fungicide and plant growth regulator products for agricultural, seed protection and professional use. Valent is a leader in marketing and sales of both traditional chemical products and also biorational products developed by its affiliate, Valent BioSciences Corporation.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Valent BioSciences Corporation Unveils its State-of-the-Art Biorational Manufacturing Facility in Osage, Iowa

FOR IMMEDIATE RELEASE

Grand opening event signifies a new era in integrated crop production

OSAGE, IA., June 27, 2014 – Valent BioSciences Corporation (VBC) today marked the official opening of its new $146 million biorational manufacturing facility in Osage, IA in a ceremony that included more than 130 international dignitaries, state and local VIPs, and media personnel. VBC is the global leader in the discovery, development, manufacturing, and commercialization of biorational products for agriculture, public health, and forestry.

Located on an expansive 73-acre site, the new 130,000 square foot plant is the largest purpose-built biorational facility in the world and will serve as the manufacturing and quality control center for VBC’s broad portfolio of fermentation products. VBC brands are derived from biological origins and provide economic, health, and environmental benefits for agriculture, public health, and forestry markets in 95 countries around the globe.

“This is a landmark day for Valent BioSciences, our parent Sumitomo Chemical Company (SCC), and for the entire biorational segment,” said Ted Melnik, VBC Executive Vice President and COO. “Not only does this investment reflect the rapid growth of our business and validate the value of biorational technology in the marketplace, it puts us in the position to meet the rising demand for our products as we continue to develop new and innovative solutions for our customers around the world.”

The opening of the new plant comes on the heels of VBC’s acquisition of Pace International, LLC (Pace), in early 2013 and its announcement of a long term strategic alliance with Biomar Microbial Technologies (Biomar) in February of this year. The Pace acquisition made SCC the first multinational supplier to offer both conventional and biorational product solutions for seed, preharvest crop production, and preharvest and postharvest crop protection applications. The Biomar alliance will create a new pipeline of industry leading, science-based products with additional work being conducted at Valent BioSciences’ research facility at Long Grove, IL.

VBC currently manufactures microbial insecticides, nematicides, and plant growth regulators used in production agriculture for managing plant growth, quality and stress in crops.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Sumitomo Chemical Company, Limited
Headquartered in Tokyo, Japan, Sumitomo Chemical Company is one of Japan’s leading chemical companies, offering a diverse range of products globally in the fields of basic chemicals, petrochemicals, IT-related chemicals and materials, health and crop science products, and pharmaceuticals. The company’s total consolidated sales for fiscal year 2013 were JPY 2.24 trillion. For additional information, visit the company’s website at www.sumitomo-chem.co.jp/english/.

About Pace International LLC
Pace International LLC collaborates with growers, packers and agricultural organizations to develop innovative solutions to enhance, protect, and preserve fruit and vegetable quality. Pace is the leading provider of postharvest solutions and technologies, equipment and technical services to maximize efficiencies in packing operations and increase the value of crops being processed. Pace International LLC is headquartered in Wapato, Washington, USA with Sales and Technical Service Offices around the world. For more information, visit http://www.paceint.com

About Biomar Microbial Technologies
Headquartered in Leon, Spain, Biomar Microbial Technologies is an independent company specialized in marine biotechnology, with one of the world ́s largest collections of marine microorganisms. For additional information, visit the company’s website at www.biomarmicrobialtechnologies.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation 847-968-4750
Email: rick.melnick@valentbiosciences.com

Download News Release

Valent BioSciences Corporation, Biomar Microbial Technologies Enter into Long-Term Strategic Alliance

FOR IMMEDIATE RELEASE

Agreement expands terms of a Research Agreement executed in 2010

LIBERTYVILLE, IL., February 4, 2014 – Valent BioSciences Corporation (VBC) and Biomar Microbial Technologies have announced the signing of a commercialization agreement under which the two companies will collaborate on the development of unique biorational products for the global agriculture, public health, and forestry markets.

VBC is the global leader in the discovery, development, manufacturing, and commercialization of biorational products. Biorationals are products typically derived from biological origins that are highly specific in their activity and provide economic, health, and/or environmental benefits. These products include microbial insecticides, fungicides and nematicides as well as plant growth regulators used in seed treatment, production agriculture, postharvest and management of stress in crops.

Biomar is a privately held company based in Leon, Spain, dedicated to the discovery of microorganisms and their fermentation products for commercial applications. Biomar owns a diverse, proprietary library of more than 66,000 microbial strains isolated from marine samples collected from around the world.

Under the expanded collaboration, Biomar will source and screen novel leads from its library while VBC provides global R&D, regulatory and commercialization resources, leveraging its network of global distribution partners. Priorities for the agreement are targeted at biofungicides, bioinsecticides, and plant growth regulator products with an emphasis on improved crop quality and productivity, plant health, and stress management.

“This agreement marks a significant investment for VBC, expanding our R&D reach into Europe and another step forward as we continue to build out our robust portfolio of biorational seed treatments, preharvest, and postharvest products,” said Ted Melnik, Executive Vice President & Chief Operating Officer of VBC. “Our work with Biomar to date has been on the cutting edge of R&D, and has already produced several promising proprietary leads. We expect to move at least two of these leads into product development this year and to develop additional screening programs with Biomar based on unmet customer needs and VBC’s strategic research targets.”

“This expanded agreement is a great opportunity to explore the full potential of our collection of marine microorganisms as a source of biorational products,” added Antonio Fernandez, Chief Executive Officer of Biomar. “We believe that marine bacteria and fungi are an unparalleled source of chemical diversity and biological activity, and our work with VBC has yielded an optimized discovery protocol that has already provided some very promising leads. We are very excited about the possibilities that this collaboration brings to our company.”

The companies will jointly own intellectual property developed under the agreement. Other terms were not disclosed.

This year, VBC will complete its construction of the world’s only dedicated, state of the art biorational manufacturing facility in Osage, Iowa. The plant will play a major role in bringing the new fermentation products developed under this agreement to VBC’s global customers.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

About Biomar Microbial Technologies
Headquartered in Leon, Spain, Biomar Microbial Technologies is an independent company specialized in marine biotechnology, with one of the world ́s largest collections of marine microorganisms. For additional information, visit the company’s website at www.biomarmicrobialtechnologies.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation 847-968-4750
Email: rick.melnick@valentbiosciences.com

Valent BioSciences Corporation Earns ISO 9001:2008 Re-certification Following a System-Wide Audit

FOR IMMEDIATE RELEASE

LIBERTYVILLE, IL., December 11, 2013 – Valent BioSciences Corporation is pleased to announce that its US-based operations have earned another three-year certification of compliance with ISO 9001:2008 standards. The certification comes as the result of a full, system-wide audit by Perry Johnson Registrars, Inc. (PJR), the first such audit since VBC achieved ISO-certification in 2010.

Valent BioSciences is a worldwide leader in the development and commercialization of biorational products. Biorationals are products typically derived from biological origins that are highly specific in their activity while providing economic, health, and/or environmental benefits. Biorational products include microbial insecticides, fungicides, and nematicides, as well as plant growth regulators used in production agriculture and for managing plant growth, quality and stress in crops.

“ISO-compliance puts VBC in a select group among biopesticide manufacturers,” said Ted Melnik, VBC Executive Vice President & Chief Operating Officer. “Our adherence to these standards reflects our firm commitment to delivering quality and value through our entire biorational portfolio to customers around the world.”

The company’s current certification applies to VBC’s management systems, and plans already are being discussed for pursuit of certification for the new state of the art biorational manufacturing facility in Osage, Iowa, scheduled to begin production in mid- 2014. Quality management of all manufacturing operations is critical to support biorational products, especially for companies such as VBC who have a truly global footprint.

This year’s audit results were particularly important – not only in terms of the auditors’ findings but also as validation for the company’s internal, continuous improvement process launched in 2010. VBC’s next full-systems audit is scheduled for 2016.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Download Press Release

Richards Joins Valent BioSciences Corporation as Plant Manager for new Osage Manufacturing Facility

FOR IMMEDIATE RELEASE

OSAGE, IA., October 22, 2013 – Valent BioSciences Corporation (VBC) announced that Karen Richards has joined the company as plant manager for VBC’s state-of-the-art biorational manufacturing facility in Osage, IA. In her new role, Richards will assume responsibility for operations at the $150 million plant, scheduled to come online in the fall of 2014.

VBC is the global leader in the development and commercialization of biorational products, with sales in 95 countries around the world. Biorationals are products typically derived from biological origins that are highly specific in their activity and provide economic, health, and/or environmental benefits. These products include microbial insecticides, fungicides and nematicides as well as plant growth regulators used in seed treatment, production agriculture, postharvest and management of stress in crops.

Richards will report to Tom Green, Vice President, Global Supply Chain and Manufacturing. “Karen comes to VBC with a history of success in several key areas,” Green said. “Her wealth of experience in fermentation technology combined with a demonstrated, results-driven approach to leadership and operational excellence positions VBC well for continued growth in the future.”

Prior to her role at VBC, Richards established a career in manufacturing that included direct responsibility for operations, quality control, engineering, maintenance, planning, buying, and adherence to Environmental Health and Safety Guidelines with one of the world’s leading pharmaceutical manufacturers. Karen earned her BS degree in chemical engineering from Purdue University and holds numerous certifications including Lean and Six Sigma.

“VBC’s investment in Osage is a testament to its commitment to its broad range of customers in agriculture, public health, and forestry around the world,” Richards said. “With accelerated growth forecast for its existing portfolio and several exciting new products in the pipeline, the need for superior manufacturing at VBC has never been greater.” Richards said. “I am excited to join the organization and look forward to helping VBC build on its reputation for producing only the highest quality biorational products.”

VBC has hired a total of 30 employees in Osage thus far. Another 31 employees will be hired over the next few months.

###

About Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company. Valent BioSciences is the worldwide leader in the development, manufacturing and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001:2008 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:
Rick Melnick
Valent BioSciences Corporation
847-968-4750
Email: rick.melnick@valentbiosciences.com

Download Press Release